Big Deals Rule: Healthcare Private Equity Midyear Update
Big Deals Rule: Healthcare Private Equity Midyear Update
1 PagesGlobal healthcare buyout activity rebounded in 2024 after a weaker 2023, returning to its long-term trajectory as economic conditions improved and sponsors sought diversification. Deal momentum showed signs of life particularly in North America, while India and Japan led activity in Asia-Pacific. Healthcare IT saw a notable revival, although limited exits in the first half of 2024 underscored the importance of clear value-creation strategies. Lower interest rates and easing inflation point to stronger dealmaking ahead, though geopolitical tensions and the upcoming US elections could temper investor confidence and slow market enthusiasm.
